123 related articles for article (PubMed ID: 33464088)
1. Design of a Biocompatible Hydroxyapatite-Based Nanovehicle for Efficient Delivery of Small Interference Ribonucleic Acid into Mouse Embryonic Stem Cells.
Zantye P; Shende S; Ramanan SR; Talukdar I; Kowshik M
Mol Pharm; 2021 Mar; 18(3):796-806. PubMed ID: 33464088
[TBL] [Abstract][Full Text] [Related]
2. Cell-penetrating peptide-conjugated lipid nanoparticles for siRNA delivery.
Asai T; Tsuzuku T; Takahashi S; Okamoto A; Dewa T; Nango M; Hyodo K; Ishihara H; Kikuchi H; Oku N
Biochem Biophys Res Commun; 2014 Feb; 444(4):599-604. PubMed ID: 24486551
[TBL] [Abstract][Full Text] [Related]
3. Cytoplasm-responsive nanocarriers conjugated with a functional cell-penetrating peptide for systemic siRNA delivery.
Tanaka K; Kanazawa T; Horiuchi S; Ando T; Sugawara K; Takashima Y; Seta Y; Okada H
Int J Pharm; 2013 Oct; 455(1-2):40-7. PubMed ID: 23911914
[TBL] [Abstract][Full Text] [Related]
4. A retro-inverso cell-penetrating peptide for siRNA delivery.
Vaissière A; Aldrian G; Konate K; Lindberg MF; Jourdan C; Telmar A; Seisel Q; Fernandez F; Viguier V; Genevois C; Couillaud F; Boisguerin P; Deshayes S
J Nanobiotechnology; 2017 Apr; 15(1):34. PubMed ID: 28454579
[TBL] [Abstract][Full Text] [Related]
5. Comparison of cationic and amphipathic cell penetrating peptides for siRNA delivery and efficacy.
Mo RH; Zaro JL; Shen WC
Mol Pharm; 2012 Feb; 9(2):299-309. PubMed ID: 22171592
[TBL] [Abstract][Full Text] [Related]
6. PEGylation rate influences peptide-based nanoparticles mediated siRNA delivery in vitro and in vivo.
Aldrian G; Vaissière A; Konate K; Seisel Q; Vivès E; Fernandez F; Viguier V; Genevois C; Couillaud F; Démèné H; Aggad D; Covinhes A; Barrère-Lemaire S; Deshayes S; Boisguerin P
J Control Release; 2017 Jun; 256():79-91. PubMed ID: 28411182
[TBL] [Abstract][Full Text] [Related]
7. Design and characterization of a new peptide vector for short interfering RNA delivery.
Chen B; Xu W; Pan R; Chen P
J Nanobiotechnology; 2015 Jun; 13():39. PubMed ID: 26054932
[TBL] [Abstract][Full Text] [Related]
8. Peptide-Based Nanoparticles to Rapidly and Efficiently "Wrap 'n Roll" siRNA into Cells.
Konate K; Dussot M; Aldrian G; Vaissière A; Viguier V; Neira IF; Couillaud F; Vivès E; Boisguerin P; Deshayes S
Bioconjug Chem; 2019 Mar; 30(3):592-603. PubMed ID: 30586303
[TBL] [Abstract][Full Text] [Related]
9. Self-fluorescence property of octa-arginine functionalized hydroxyapatite nanoparticles aids in studying their intracellular fate in R1 ESCs.
Zantye P; Talukdar I; Ramanan SR; Kowshik M
Biochem Biophys Res Commun; 2022 Oct; 627():21-29. PubMed ID: 36029534
[TBL] [Abstract][Full Text] [Related]
10. Highly efficient delivery of siRNA to a heart transplant model by a novel cell penetrating peptide-dsRNA binding domain.
Li H; Zheng X; Koren V; Vashist YK; Tsui TY
Int J Pharm; 2014 Jul; 469(1):206-13. PubMed ID: 24768403
[TBL] [Abstract][Full Text] [Related]
11. Tumor-targeted pH/redox dual-sensitive unimolecular nanoparticles for efficient siRNA delivery.
Chen G; Wang Y; Xie R; Gong S
J Control Release; 2017 Aug; 259():105-114. PubMed ID: 28159516
[TBL] [Abstract][Full Text] [Related]
12. PTD/CPP peptide-mediated delivery of siRNAs.
Presente A; Dowdy SF
Curr Pharm Des; 2013; 19(16):2943-7. PubMed ID: 23140460
[TBL] [Abstract][Full Text] [Related]
13. Design and evaluation of a stearylated multicomponent peptide-siRNA nanocomplex for efficient cellular siRNA delivery.
Wan Y; Moyle PM; Gn PZ; Toth I
Nanomedicine (Lond); 2017 Feb; 12(4):281-293. PubMed ID: 28093948
[TBL] [Abstract][Full Text] [Related]
14. Biocompatible gelatin nanoparticles for tumor-targeted delivery of polymerized siRNA in tumor-bearing mice.
Lee SJ; Yhee JY; Kim SH; Kwon IC; Kim K
J Control Release; 2013 Nov; 172(1):358-366. PubMed ID: 24036198
[TBL] [Abstract][Full Text] [Related]
15. Cell penetrating peptide-mediated systemic siRNA delivery to the liver.
Hayashi Y; Yamauchi J; Khalil IA; Kajimoto K; Akita H; Harashima H
Int J Pharm; 2011 Oct; 419(1-2):308-13. PubMed ID: 21827843
[TBL] [Abstract][Full Text] [Related]
16. Nanocarrier Mediated siRNA Delivery Targeting Stem Cell Differentiation.
Fernandes F; Kotharkar P; Chakravorty A; Kowshik M; Talukdar I
Curr Stem Cell Res Ther; 2020; 15(2):155-172. PubMed ID: 31789134
[TBL] [Abstract][Full Text] [Related]
17. Systemic delivery of siRNA by T7 peptide modified core-shell nanoparticles for targeted therapy of breast cancer.
Yu MZ; Pang WH; Yang T; Wang JC; Wei L; Qiu C; Wu YF; Liu WZ; Wei W; Guo XY; Zhang Q
Eur J Pharm Sci; 2016 Sep; 92():39-48. PubMed ID: 27355138
[TBL] [Abstract][Full Text] [Related]
18. Cell-penetrating peptides for siRNA delivery to glioblastomas.
Srimanee A; Arvanitidou M; Kim K; Hällbrink M; Langel Ü
Peptides; 2018 Jun; 104():62-69. PubMed ID: 29684592
[TBL] [Abstract][Full Text] [Related]
19. Rational modification of oligoarginine for highly efficient siRNA delivery: structure-activity relationship and mechanism of intracellular trafficking of siRNA.
Chu D; Xu W; Pan R; Ding Y; Sui W; Chen P
Nanomedicine; 2015 Feb; 11(2):435-46. PubMed ID: 25193363
[TBL] [Abstract][Full Text] [Related]
20. siRNA delivery using amphipathic cell-penetrating peptides into human hepatoma cells.
Furukawa K; Tanaka M; Oba M
Bioorg Med Chem; 2020 Apr; 28(8):115402. PubMed ID: 32146061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]